IOLCP Q3 & M9 FY26 Analyst Call Audio Recording Available
IOL Chemicals and Pharmaceuticals Limited has released the audio recording of its Q3 & M9 FY26 analyst and investor call, held on February 12, 2026. The recording is available via a provided link.
This is a standard post-earnings disclosure and does not introduce new material information that would significantly impact the company's stock price or valuation.
The announcement is a routine disclosure of an audio recording of a post-earnings call and does not contain new financial information or forward-looking statements that would alter the company's outlook.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has made available the audio recording of its Analysts/Investors Call concerning the company's financial performance for the third quarter (Q3) and the first nine months (M9) of the fiscal year 2026 (FY26). The call was held on 12th February 2026.
The link to the audio recording is provided as: https://www.iolcp.com//uploads/10040405.mp3.
This announcement is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company requests stakeholders to take this information on record.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.